Category: Let’s interview series

Co-founded with Prof. Toshiyoshi Fujiwara1, the inventor of the telomerase specific oncolytic adenovirus technology, Oncolys BioPharma is committed to make its therapeutic and diagnostic products available for patients with intractable cancers. Venture Valuation (VV) interviewed Yasunari Kashihara, Vice President, Business Development, and Kohei Hata, Deputy Director, Corporate Development Read the interview

Read more

Having leverage with its proprietary cell sheet engineering platform technology1, Cellseed is going to commercialize two products for which the regenerative medicine market has hardly waited. hardly waited for Venture Valuation (VV) interviewed the CEO, Dr. Setsuko Hashimoto Read the interview

Read more

Pioneering research on biomolecular diffusion in nanofluidics, Abionic has developed the abioSCOPE, an in-vitro platform performing quantitative diagnostic testing. Its first application products: abioKIT Total IgE (1 test in 5min) and abioKIT Aeroallergens (6 tests in 12 min) are now available in the POC diagnostic market in Europe, and in 2016 in the U.S. Venture … Continue reading Interviews with leading Life Sciences companies: Abionic SA

Read more